| Psoriatic Arthritis |
1 |
1 |
| Prostate Cancer |
0 |
0.94 |
| Prostate Specific Antigen |
0 |
0.91 |
| Rheumatoid Arthritis |
0 |
0.39 |
| Cardiovascular Risk Management |
0 |
0.36 |
| Biologic Therapy |
0 |
0.24 |
| Spondylitis, Spondylosis, Kyphosis |
0 |
0.24 |
| Arthritis |
0 |
0.23 |
| Herpes Zoster |
0 |
0.21 |
| Cancer |
0 |
0.15 |
| Disease-Modifying Antirheumatic Drugs |
0 |
0.15 |
| Coronary Artery Disease (CAD) |
0 |
0.11 |
| Metabolic Syndrome |
0 |
0.1 |
| Ulcerative Colitis |
0 |
0.1 |
| Ankylosing Spondylitis |
0 |
0.08 |
| Cardiometabolic Risk Factors |
0 |
0.08 |
| Cardiovascular disease |
0 |
0.08 |
| Colitis |
0 |
0.08 |
| Dermatoses |
0 |
0.08 |
| Immunization |
0 |
0.08 |
| Intravenous |
0 |
0.08 |
| Metabolism |
0 |
0.08 |
| Patient History |
0 |
0.08 |
| Small Molecule Inhibitor |
0 |
0.08 |
| Thrombosis |
0 |
0.08 |
| Tumor |
0 |
0.08 |
| Tyrosine Kinase |
0 |
0.08 |
| Inflammatory Bowel Disease |
0 |
0.07 |
| Psoriasis |
0 |
0.07 |
| Thromboembolism |
0 |
0.07 |